Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, announced the closing of an oversubscribed...
Lexicon Pharmaceuticals, Inc. announced that Viatris Inc. has obtained an exclusive license from Lexicon to commercialize sotagliflozin outside of the United States and Europe...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Xaira Therapeutics announced the appointment of Dr. Debbie Law to its C-suite. Law will serve as chief scientific officer.
Xaira Therapeutics launched in April on...
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced the appointment of Aaron Sato, Ph.D.,...
